Blog

Harvey Castro: Honored to Join the Editorial Board of AI in Precision Oncology

Collage photo of Douglas Flora and Harvey Castro

Sep 16, 2024, 13:09

Harvey Castro: Honored to Join the Editorial Board of AI in Precision Oncology

Douglas Flora shared a post by Harvey Castro, on LinkedIn, adding:

“Harvey Castro We are thrilled to have you join our growing team of esteemed AI in Precision Oncology editorial board members!

Your expertise, input, and contributions will be instrumental in spreading the word about the incredible power and promise these tools bring to the future of oncology care. Thank you for your support—your insights will help us drive meaningful conversations and advancements in the field.

We look forward to your continued input and the exciting manuscripts you’ll bring (and review) to help shape the future of precision oncology!”

Quoting Harvey Castro‘s post:

“Transforming Cancer Care with AI: Honored to Join the Editorial Board of AI in Precision Oncology

I am humbled to announce that I have joined the editorial board of the prestigious journal, AI in Precision Oncology. This journal is at the forefront of exploring how artificial intelligence can revolutionize cancer care by enhancing precision medicine and improving outcomes in oncology.

Our latest special issue, expertly guest-edited by Dr. Toufic Kachaamy, focuses on Cancer Screening—highlighting innovative research and advancements that leverage AI for early detection and more accurate diagnosis. These insights are crucial in the ongoing fight against cancer, providing new pathways for personalized treatment and patient care.

Being part of this incredible team of leading experts and visionaries is an honor. Together, we are committed to driving progress in AI-driven oncology, fostering collaboration, and sharing groundbreaking knowledge to make a real impact on patients’ lives.

I extend my deepest gratitude to the outstanding editorial team, contributors, and thought leaders who continuously push the boundaries of innovation in healthcare.

Stay tuned as we continue to explore and share the latest advancements in AI and oncology. Let’s work together to create a future where technology and medicine unite to fight cancer more effectively.

Discover more about our work and access the special issue!

Douglas Flora (thank you for adding me to the team).”

Source: Douglas Flora/LinkedIn and Harvey Castro/LinekdIn

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.

Harvey Castro is an advisor at Phantom Space and an IT consultant for the Texas Medical Association. He serves on the Health Regulatory Advisory Panel for Singapore’s Ministry of Health and is the Chief Medical AI Officer at Helpp.ai. Additionally, he is an editorial board member at HealthManagement.org.